USITC to investigate blood separation devices

The US International Trade Commission (ITC) has instituted an investigation into certain blood separation and cell preparation devices.

In a  notice of investigation yesterday, March 7, the ITC said the investigation was based on a complaint filed by biotechnology company  RegenLab on February 4.

RegenLab named two medical technology companies—Israel-based  Estar Technologies and Texas-based  Eclipse MedCorp—in its complaint.

It said the companies had imported and sold devices in the US that infringed one of its patents (US number 10,064,894) which covers methods and devices for cell preparations.

According to RegenLab, the companies’ sold “blood separation and cell preparation devices that allow clinicians to collect a patient’s blood and separate platelet rich plasma from the blood”.

The ITC said Estar and Eclipse must submit responses to the complaint within 20 days.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.